She is recognised internationally as a leading clinician scientist whose work has led to new insights into the breast cancer immunology field as well as leading international clinical trials in breast cancer immunotherapy. To date, she has published over 285 peer-reviewed research articles with a lifetime H-index of more than 100. Her recent work has been highly influential: she is ranked in the top 1% of highly cited researchers globally by the Web of Science. She Co-Chairs the International Breast Cancer Study Group (IBCSG) based in Bern, Switzerland, one of the largest global academic breast cancer trial cooperative groups. She is a current holder of the Inaugural National Breast Cancer Foundation (NBCF) of Australia Endowed Chair. In 2021, Professor Loi received the Frank Fenner Prize for Life Scientist of the Year in the Prime Minister’s Prizes for Science, and the Australian Academy of Health and Medical Sciences’ Jian Zhou Medal. In 2022 she was inducted into the Victorian Honour Roll of Women in recognition of her remarkable leadership and excellence in her field.